Completed NA INTERVENTIONAL 3-arm NCT00812279

Investigate the Exposure to Selected Smoke Constituents in Smokers Switching to Distillation Based Smoking Article

A Controlled, Randomised, Open-label, 3-arm Parallel Single-centre Confinement Study to Investigate Exposure to Selected Smoke Constituents in Smokers Switching From Conventional Cigarettes to SMAR Cigarettes for 5 Days

Sponsor: Philip Morris Products S.A.

Conditions Smoking

Interventions Distillation based smoking article (SMAR cigarette) conventional cigarette smoking cessation

Updated 6 times since 2017 Last updated: Nov 5, 2019 Started: Nov 30, 2008 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00812279, this NA trial focuses on Smoking and remains completed. Sponsored by Philip Morris Products S.A., it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philip Morris Products S.A.

Data source: Philip Morris Products S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland